Skip to main content

Table 1 Characteristics of exenatide once weekly studies

From: Association among weight change, glycemic control, and markers of cardiovascular risk with exenatide once weekly: a pooled analysis of patients with type 2 diabetes

Author N Study duration (weeks) Baseline A1C (%) a Change in A1C (%) a,b Baseline body weight (kg) a Change in body weight (kg) a,b
Drucker et al. 2008 [14] 148 30 8.3 −1.9 102 −3.7
(DURATION-1)
Bergenstal et al. 2010 [9] 160 26 8.6 −1.5 89 −2.3
(DURATION-2)
Diamant et al. 2010 [13] 233 26 8.3 −1.5 91.2 −2.6
(DURATION-3)
Russell-Jones et al. 2012 [16] 248 26 8.5 −1.5 87.5 −2.0
(DURATION-4)
Blevins et al. 2011 [10] 129 24 8.5 −1.6 97.0 −2.3
(DURATION-5)
Buse et al. 2013 [11] 461 26 8.5 −1.3 90.9 −2.7
(DURATION-6)
Davies et al. 2013 [12] 111 26 8.4 −1.3 96.7 −2.7
Ji et al. 2013 [15] 340 26 8.7 −1.4 69.6 −1.6
  1. A1C: glycated hemoglobin; aAll mean or least-squares mean values; bAt study end point.